StockWatch
·

LifeMD, Inc. Q1 FY26 Results

LFMDQ1 FY26 Results
Filing
MetricValue ($ M)Q1 FY25
Revenue50.1623.6%
Total Income50.1623.6%
Expenditure59.096.4%
PBT-8.87
Net Profit-8.87742.8%
OPM-17.80%21.67pp
NPM-17.69%19.80pp
EPS-0.20
View full financials

LifeMD Reports Q1 2026 Revenue of $50.2 Million

07 May 2026 · 7 May, 2:37 am

Summary

LifeMD, Inc. reported first quarter 2026 financial results, with revenue of $50.2 million and an adjusted EBITDA loss of $4.5 million. The company's gross margin improved to 88%, driven by favorable revenue mix and lower fulfillment costs. Active telehealth subscribers increased 26% year-over-year to over 365,000. LifeMD reaffirmed its full year 2026 revenue guidance of $220 million to $230 million and adjusted EBITDA of $12 million to $17 million.

Key Highlights

  1. 1

    LifeMD reported first quarter 2026 revenue of $50.2 million, exceeding its guidance range.

  2. 2

    The company's adjusted EBITDA loss for Q1 2026 was $4.5 million, aligning with guidance.

  3. 3

    Gross margin increased by approximately 420 basis points to 88% compared to the first quarter of 2025.

  4. 4

    Weight management new-patient revenues grew approximately 120% versus the fourth quarter of 2025.

  5. 5

    Active telehealth subscribers increased 26% year-over-year to over 365,000 at quarter end.

  6. 6

    The company exited the quarter with $34.5 million of cash and no debt.

  7. 7

    LifeMD affirmed full year 2026 revenue guidance of $220 million to $230 million and adjusted EBITDA of $12 million to $17 million.

Management Comments

J

Justin Schreiber

Q1 was a strong start to 2026. We added more than 42,000 net telehealth subscribers, the largest quarterly net addition in our history. We ended the quarter with over 365,000 subscribers. In weight management, sign-ups increased approximately 120% sequentially from Q4, and we exited the quarter with strong momentum across all of our key growth areas. LifeMD is no longer just a telehealth company focused on a handful of conditions. We are building what we believe can become one of the most important virtual healthcare platforms in the country — a trusted destination where patients can access care, medications, labs, insurance-supported services, and ongoing clinical support through one connected experience. Our platform is uniquely positioned to support both direct-to-consumer self-pay and insurance-covered programs, and we are seeing continued traction with strong unit economics across our insurance-sponsored offerings. As previously guided, we are on track to expand coverage to approximately 230 million lives this month and believe our benefits infrastructure will be a key driver of long-term growth. At the same time, our women’s health business delivered exceptional performance in the quarter, with strong retention and improved customer acquisition costs supporting scalable, high-quality growth. Looking ahead, we are energized by the momentum across the business, with multiple strategic partnerships and new product launches in men’s and women’s health expected in the coming months, positioning us to drive continued top-line growth and profitability throughout the year.

A

Atul Kavthekar

The first quarter played out largely as we expected: strong subscriber momentum, following a planned step-up in patient acquisition spend, and the early benefits of platform efficiency beginning to show in our gross margin. Revenue for the first quarter was $50.2 million, exceeding our guidance range of $48 million to $49 million, with nearly all revenue derived from recurring subscriptions. The number of active subscribers increased approximately 26% year-over-year to over 365,000 at quarter end, with over 42,000 net adds in Q1, the largest quarterly net addition in our history. We exited the quarter with $34.5 million in cash, no debt, and a $30 million undrawn revolving credit facility that we put in place at the start of the year. Our balance sheet remains a strategic asset, providing ample flexibility to fund our expanding growth initiatives.

Informational and educational content only. Not investment advice.